General Characteristics and Origin
These medicinal products belong to the group of polypeptides of endogenous origin. They are obtained from animal immune system organs, specifically the thymus gland of cattle. Historically, these medications are considered the first representatives of their class in pharmacology.
This group includes well-known agents such as Timalin and T-activin. Structurally, they are complex mixtures of polypeptide fractions.
Pharmacodynamics and Immunological Effects
Biologically active substances from the thymus gland exert a complex, multilevel effect on the body's defense mechanisms:
- T-cell link: promote the restoration of total counts and functional activity of T-lymphocytes, and normalize the balance of their subpopulations (regulate the T-helper to T-suppressor ratio).
- B-cell link: help achieve a physiological ratio of T- and B-lymphocytes in the body.
- Nonspecific resistance: increase the functional activity of natural killer cells (NK cells) and significantly enhance phagocytosis.
- Mediators: stimulate the production of lymphokines.
Clinical Application and Limitations
In medical practice, these pharmacological agents are traditionally prescribed as part of combination therapy for patients exhibiting a marked decrease in cellular immunity.
Nevertheless, modern medical science approaches such prescriptions with caution. A crucial note is that the actual efficacy and clinical necessity of using such agents have not been proven in rigorous clinical trials.
Adverse Effects
Like any complex protein preparations of animal origin, these medications carry specific risks when administered to patients.
The primary and most likely adverse effect associated with these drugs is the occurrence of various allergic reactions.